Faizaan I. Khan, Najm S. Khan, Heli Majeethia, Jihwan Park, Roshan Dongre, Franklin Wu, Ella Brissett, Masayoshi Takashima, Omar G. Ahmed
{"title":"Obstacles to Obtain Care Among Sexual and Gender Minorities With Chronic Rhinosinusitis","authors":"Faizaan I. Khan, Najm S. Khan, Heli Majeethia, Jihwan Park, Roshan Dongre, Franklin Wu, Ella Brissett, Masayoshi Takashima, Omar G. Ahmed","doi":"10.1002/lio2.70202","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objectives</h3>\n \n <p>This study aims to compare the prevalence of cost and non-cost barriers to healthcare access among sexual and gender minority (SGM) patients and non-SGM patients with chronic rhinosinusitis (CRS).</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>The All of Us Research Program was queried for CRS patients, defined as having at least two diagnoses of chronic sinusitis (ICD10: J32.x). Patients were categorized based on questions regarding gender identity, biological sex, and self-descriptions. The primary outcome was cost and non-cost barriers. Multivariable logistic regression was used to examine SGM status and experiencing barriers to care.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>7708 patients with CRS were included; 595 were SGM and 7113 were non-SGM. SGM patients were significantly more likely to delay primary care (AOR: 1.51, 95% CI: 1.09–2.11), specialist care (AOR: 1.54, 95% CI: 1.18–2.00), mental healthcare (AOR: 1.70, 95% CI: 1.29–2.24), and filling prescription medication (AOR: 1.31, 95% CI: 1.03–1.66). Regarding non-cost barriers, SGM patients were significantly more likely to delay care because of transportation problems (AOR: 1.84, 95% CI: 1.39–2.42), their provider having a different background (AOR: 1.48, 95% CI: 1.14–1.90) and due to a lack of respect by their providers (AOR: 1.42, 95% CI: 1.16–1.73).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>SGM patients with CRS report multiple cost and non-cost barriers. While differences between CRS and non-CRS groups were modest, rhinologists and other healthcare practitioners treating SGM patients with CRS should be mindful of these disparities to address these barriers at a patient and system level.</p>\n </section>\n \n <section>\n \n <h3> Level of Evidence</h3>\n \n <p>Level III, 2025.</p>\n </section>\n </div>","PeriodicalId":48529,"journal":{"name":"Laryngoscope Investigative Otolaryngology","volume":"10 4","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/lio2.70202","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Laryngoscope Investigative Otolaryngology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/lio2.70202","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives
This study aims to compare the prevalence of cost and non-cost barriers to healthcare access among sexual and gender minority (SGM) patients and non-SGM patients with chronic rhinosinusitis (CRS).
Methods
The All of Us Research Program was queried for CRS patients, defined as having at least two diagnoses of chronic sinusitis (ICD10: J32.x). Patients were categorized based on questions regarding gender identity, biological sex, and self-descriptions. The primary outcome was cost and non-cost barriers. Multivariable logistic regression was used to examine SGM status and experiencing barriers to care.
Results
7708 patients with CRS were included; 595 were SGM and 7113 were non-SGM. SGM patients were significantly more likely to delay primary care (AOR: 1.51, 95% CI: 1.09–2.11), specialist care (AOR: 1.54, 95% CI: 1.18–2.00), mental healthcare (AOR: 1.70, 95% CI: 1.29–2.24), and filling prescription medication (AOR: 1.31, 95% CI: 1.03–1.66). Regarding non-cost barriers, SGM patients were significantly more likely to delay care because of transportation problems (AOR: 1.84, 95% CI: 1.39–2.42), their provider having a different background (AOR: 1.48, 95% CI: 1.14–1.90) and due to a lack of respect by their providers (AOR: 1.42, 95% CI: 1.16–1.73).
Conclusion
SGM patients with CRS report multiple cost and non-cost barriers. While differences between CRS and non-CRS groups were modest, rhinologists and other healthcare practitioners treating SGM patients with CRS should be mindful of these disparities to address these barriers at a patient and system level.